FIELD: chemistry.
SUBSTANCE: invention refers to cyclic sulphonamide derivatives of general formula I where bonds indicated with wavy lines represent mutually cis- in relation to cyclohexane ring; R3 represents H or hydrocarbon group having up to 10 carbon atoms; Ar1 and Ar2 independently represent phenyl which carries 0-3 substitutes independently selected from halogen, CF3, CHF2; or its pharmaceutically acceptable salt. Besides, invention refers to technology of compounds of general formula I and to pharmaceutical composition based on compounds of general formula I and applied as gamma-secretase inhibitor.
EFFECT: new derivatives of cyclic sulphonamide, activating gamma-secretase inhibition and suitable for treatment and prevention of Alzheimer's disease.
9 cl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
PYRIDYL DIMETHYLSULPHONIC DERIVATIVE | 2006 |
|
RU2404968C2 |
TRIAZOLE COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND ANTIFUNGAL COMPOSITION | 1996 |
|
RU2146250C1 |
DERIVATIVES OF AZETHIDINONE, PHARMACEUTICAL COMPOSITION SHOWING HYPOCHOLESTEROLEMIC ACTIVITY AND METHOD OF SERUM CHOLESTEROL LEVEL DECREASE | 1994 |
|
RU2138480C1 |
DERIVATIVES OF 3-OXO-1-CYCLOBUTENE AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2002 |
|
RU2296753C2 |
HETEROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION AND METHOD OF INHIBITION OF 5-LIPOXYGENASE ACTIVITY | 1995 |
|
RU2136666C1 |
P38 INHIBITORS AND APPLICATION METHODS | 2004 |
|
RU2357957C2 |
DERIVATIVES OF PROPIONIC ACIDS AND THEIR USING AS hPPARs ACTIVATORS | 2003 |
|
RU2316539C2 |
SUBSTITUTED PYRIMIDINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, OR N-OXIDES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1992 |
|
RU2113437C1 |
N-HYDROXYLUREAS AS ANTI-INFLAMMATORY AGENTS | 1995 |
|
RU2152935C2 |
PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS | 2006 |
|
RU2420519C2 |
Authors
Dates
2008-09-27—Published
2004-05-07—Filed